Corcept Therapeutics | Bienes





Bienes Cambio Fecha
Acadia Pharmaceuticals USD 1.33B 105.22M 2025-09
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
ANI Pharmaceuticals USD 1.41B 65.15M 2025-09
Ardelyx USD 486.17M 19.4M 2025-09
Aurora Cannabis CAD 756.86M 80.98M 2025-09
BioMarin Pharmaceutical USD 7.61B 158.53M 2025-09
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Canopy Growth CAD 1.07B 165.17M 2025-09
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Eli Lilly USD 114.94B 14.01B 2025-09
J&J USD 192.82B 573M 2025-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Merck USD 129.55B 12.02B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Pacira USD 1.3B 239.68M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Supernus Pharmaceuticals USD 1.42B 37.35M 2025-09
TG Therapeutics USD 1.03B 322.41M 2025-09


Corcept Therapeutics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.